Product Images Piqray
View Photos of Packaging, Labels & Appearance
- alpelisib structural formula - byl719 01
- Figure 1: Progression Free Survival in SOLAR-1 (Per Investigator Assessment of Patients with a PIK3CA Tumor Mutation) - byl719 02
- PRINCIPAL DISPLAY PANEL NDC 0078-0708-02 PIQRAY® (alpelisib) tablets 300 mg daily dose Take two 150 mg tablets once daily Rx only Usual Dosage: Take two 150 mg tablets once daily with food. Swallow tablets whole. DO NOT chew,crush, or split tablets. See prescribing information for complete dosage information. 28-Day Supply Contains: Two 14-day blister packs each containing 28 tablets NOVARTIS - byl719 03
- PRINCIPAL DISPLAY PANEL NDC 0078-0715-02 PIQRAY® (alpelisib) tablets 250 mg daily dose Take one 200 mg tablet and one 50 mg tablet once daily Rx only Usual Dosage: Take one 200 mg tablet and one 50 mg tablet once daily with food. Swallow tablets whole. DO NOT chew, crush, or split tablets. See prescribing information for complete dosage information. 28-Day Supply Contains: Two 14-day blister packs each containing 28 tablets: 200 mg 14 tablets per pack 50 mg 14 tablets per pack NOVARTIS - byl719 04
- PRINCIPAL DISPLAY PANEL NDC 0078-0701-84 PIQRAY® (alpelisib) tablets 200 mg daily dose Take one 200 mg tablet once daily Rx only Usual Dosage: Take one 200 mg tablet once daily with food. Swallow tablets whole. DO NOT chew, crush, or split tablets. See prescribing information for complete dosage information. 28-Day Supply Contains: One blister pack containing 28 tablets NOVARTIS - byl719 05
Product Label Images
The following 5 images provide visual information about the product associated with Piqray NDC 0078-0715 by Novartis Pharmaceuticals Corporation, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
alpelisib structural formula - byl719 01
Figure 1: Progression Free Survival in SOLAR-1 (Per Investigator Assessment of Patients with a PIK3CA Tumor Mutation) - byl719 02
PRINCIPAL DISPLAY PANEL NDC 0078-0708-02 PIQRAY® (alpelisib) tablets 300 mg daily dose Take two 150 mg tablets once daily Rx only Usual Dosage: Take two 150 mg tablets once daily with food. Swallow tablets whole. DO NOT chew,crush, or split tablets. See prescribing information for complete dosage information. 28-Day Supply Contains: Two 14-day blister packs each containing 28 tablets NOVARTIS - byl719 03
L4 Piqray 300 mg daily dose is a medication manufactured by Novartis Pharma Stein AG, distributed by Novartis Pharmaceuticals Corporation, for oral use. The drug, which contains 150mg alpelisib per tablet, is taken twice daily with food. It is important to swallow the tablets whole and not to chew, crush, or split them. It is available in a 28-day supply package containing two blister packs, each pack containing 28 tablets. For complete dosage information, kindly refer to the prescribing information. The drug should be stored between 20°C to 25°C. For more information or in case of queries, visit www.PIQRAY.com or call 1-888-669-6682.*
PRINCIPAL DISPLAY PANEL NDC 0078-0715-02 PIQRAY® (alpelisib) tablets 250 mg daily dose Take one 200 mg tablet and one 50 mg tablet once daily Rx only Usual Dosage: Take one 200 mg tablet and one 50 mg tablet once daily with food. Swallow tablets whole. DO NOT chew, crush, or split tablets. See prescribing information for complete dosage information. 28-Day Supply Contains: Two 14-day blister packs each containing 28 tablets: 200 mg 14 tablets per pack 50 mg 14 tablets per pack NOVARTIS - byl719 04
PIQRAY is a medicine that comes in tablets and is meant for oral use. This drug is manufactured by Novartis Pharma Stein AG in Switzerland and distributed by Novartis Pharmaceuticals Corporation in the United States. The recommended dosage is one 200mg tablet and one 50mg tablet to be taken once daily with food, and the tablets should not be crushed, chewed, or split. The proper storage temperature of the tablets should be maintained in the range of 20° C to 25° C (68° F to 77° F). PIQRAY is available for prescription only, and more information can be found via the website or phone number provided by Novartis.*
PRINCIPAL DISPLAY PANEL NDC 0078-0701-84 PIQRAY® (alpelisib) tablets 200 mg daily dose Take one 200 mg tablet once daily Rx only Usual Dosage: Take one 200 mg tablet once daily with food. Swallow tablets whole. DO NOT chew, crush, or split tablets. See prescribing information for complete dosage information. 28-Day Supply Contains: One blister pack containing 28 tablets NOVARTIS - byl719 05
"PIQRAY" tablets (alpelisib 200mg) are taken orally once daily with food. Each pack contains 28 tablets and should be kept in the original container between 20°C to 25°C (68°F to 77°F). Tablets must not be chewed, crushed, or split. PIQRAY is a product of Scvania ENovartis, manufactured by Novartis Pharma Stein AG and distributed by Novartis Pharmaceuticals Corporation. For complete dosage information, please refer to the prescribing information or visit www.PIQRAY.com. Contact 1-888-669-6682 for further inquiries.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.
